In accordance
with 5 CFR 1320, OMB is filing comment and withholding approval at
this time. The agency shall examine public comment in response to
the proposed rulemaking and will include in the supporting
statement of the next ICR--to be submitted to OMB at the final rule
stage--a description of how the agency has responded to any public
comments on the ICR, including comments on maximizing the practical
utility of the collection and minimizing the burden.
Inventory as of this Action
Requested
Previously Approved
09/30/2021
36 Months From Approved
09/30/2021
2,929
0
2,929
3,763
0
3,763
13,082
0
13,082
This ICR covers provisions under the
Montreal Protocol on Substances that Deplete the Ozone Layer
(Montreal Protocol) and Title VI of the CAA that establish limits
on total U.S. production, import, and export of class I and class
II ODS (or controlled substances). Production and import of class I
controlled substances (chlorofluorocarbons and others) was phased
out in the United States. The phaseout excludes exemptions for
essential uses, critical uses of methyl bromide, quarantine and
pre-shipment uses of methyl bromide, previously used material, and
material that will be transformed or destroyed. There are also use
restrictions and reduction schedules leading to the eventual
phaseout of class II controlled substances, with exemptions for
previously used material and material that will be transformed or
destroyed. To implement the CAA and meet commitments under the
Montreal Protocol, the ozone-depleting substances (ODS) phaseout
regulations establish control measures for individual companies.
The EPA monitors compliance through the recordkeeping and reporting
requirements established in the regulations at 40 CFR part 82,
Subpart A. The EPA is requiring electronic reporting, removing
reporting elements that are no longer needed, and revising others
to address changes to the upgraded electronic ODS Tracking System
(ODSTS). The EPA is also closing a gap in the certification for the
purchase of methyl bromide under the quarantine and preshipment
exemption. This ICR is also associated with amendments to the
previously existing recordkeeping and reporting requirements
governing the petition to import used controlled substances for
reuse or destruction in the United States. Persons that import
controlled substances for destruction in the United States and
persons that destroy controlled substances in the United States are
required to abide by the recordkeeping and reporting requirements.
In this final action, the EPA also modified the petition process to
import used ODS to explicitly note that the Agency may need to
follow up for additional information to verify that the ODS is in
fact used. Therefore, this rule-related ICR covers reporting
requirements related to the production, import, export,
transformation, destruction, transshipment, and exempted uses of
all ODS, and incorporates final requirements for electronic
reporting for class I and class II substances.
The estimated burden hours and
labor costs have decreased compared to currently approved ICR. This
is because the rule-related ICR accounts for the transition from
paper to electronic reporting. Even accounting for the one-time
burden associated with the transition to electronic reporting
(i.e., CDX registration and CDX electronic signature), the
electronic reporting results in overall burden reduction for
respondents. While the one-time burden associated with the
transition to electronic reporting (i.e., CDX registration and
electronic signature) temporarily increases burden, overall burden
decreases because of the efficiencies associated with electronic
reporting.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.